BusinessFibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)By Nasdaq OMXApr 18, 2016, 12:00 PM UTC
BusinessConatus Late Breaker Oral Presentation at EASL Details Phase 2 Liver Cirrhosis Trial Three-month DataBy Nasdaq OMXApr 18, 2016, 11:30 AM UTC
BusinessLifeSci Advisors Announces Comprehensive Action Plan to Advance Gender Diversity in the Life Sciences IndustryBy Nasdaq OMXApr 15, 2016, 5:54 PM UTC
BusinessNewLink Genetics Receives $2.8 Million Award from DTRA to Develop a Multivalent Filovirus VaccineBy Nasdaq OMXApr 15, 2016, 11:00 AM UTC
BusinessCord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2016 Financial ResultsBy Nasdaq OMXApr 14, 2016, 9:00 PM UTC
BusinessAdamas Announces Data Update at the 68th American Academy of Neurology Annual MeetingBy Nasdaq OMXApr 14, 2016, 8:05 PM UTC
BusinessUS Patent Issued to LifeVantage for TrueScience Product CompositionBy Nasdaq OMXApr 14, 2016, 1:00 PM UTC
BusinessArbutus Presents Data on HBV Capsid Assembly Inhibitor AB-423 at EASL 2016By Nasdaq OMXApr 14, 2016, 12:00 PM UTC
